封面
市場調查報告書
商品編碼
1624389

全球膽固醇篩檢/膽固醇實驗室檢測服務市場規模(按客戶類型、地區、範圍和預測)

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Size By Type Of Customer, By Competitive Landscape, By Geography Scope And Forecast

出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

膽固醇篩檢/膽固醇實驗室檢測服務市場規模與預測

2020 年膽固醇篩檢/膽固醇實驗室檢測服務市場規模價值 154 億美元,預計到 2028 年將達到 286 億美元,2021 年至 2028 年的複合年增長率為 7.9%。

心血管疾病和肥胖症的盛行率不斷上升、醫生更傾向於實驗室檢測而非自我檢測、政府努力提高檢測品質以及老齡人口的快速增長,這些因素都促使膽固醇篩檢的減少。/推動膽固醇篩檢成長的因素膽固醇實驗室檢測服務市場。全球膽固醇篩檢/膽固醇實驗室檢測服務市場報告對市場進行了全面的評估。它對關鍵細分市場、趨勢、市場推動因素、阻礙因素、競爭格局以及在市場中發揮關鍵作用的因素進行了全面的分析。

全球膽固醇篩檢/膽固醇實驗室檢測服務市場定義

久坐生活方式的盛行預計將增加全球對膽固醇實驗室檢測的需求。膽固醇是一種蠟狀、脂肪狀物質,存在於血液、神經纖維和身體器官中。一個人的膽固醇水平取決於遺傳、食用富含飽和脂肪的食物(如動物產品)、代謝疾病(如糖尿病)、年齡和性別等因素。

全球膽固醇篩檢/膽固醇實驗室檢測服務市場概況

膽固醇水平升高會增加健康風險,包括增加中風和心臟病的風險,並且是促使死亡的主要原因。膽固醇實驗室測試能夠及早發現問題,避免併發症並增加患者生存的機會,從而推動膽固醇篩檢/膽固醇實驗室測試服務市場的成長。

其他推動市場成長的關鍵因素包括:人們對膽固醇危害的認識不斷提高,以及對膽固醇檢測重要性的教育不斷加強,心血管疾病、中風和其他心臟疾病的盛行率不斷上升,以及醫療保健支出不斷增加。低、偏好快餐以及缺乏體能訓練)等因素的推動。

肥胖也是一種與高膽固醇有關的疾病。隨著與膽固醇相關的疾病的增加,對此類檢測的需求也將增加,從而擴大全球實驗室膽固醇檢測市場。然而,由於非侵入性膽固醇檢測方法的引入以及家庭或自我檢測試劑盒的存在,可能會限製成長。

目錄

第1章全球膽固醇篩檢/膽固醇實驗室檢測服務市場:簡介

    市場概況
  • 研究範圍
  • 先決條件

第 2 章執行摘要

第 3 章:經過驗證的市場研究方法

  • 資料探勘
  • 驗證
  • 主要來源
  • 資料來源列表

第4章 全球膽固醇篩檢/膽固醇實驗室檢測服務市場展望

  • 概述
  • 市場動態
    • 驅動程式
    • 阻礙因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章 全球膽固醇篩檢/膽固醇實驗室檢測服務市場(依客戶類型)

  • 概述
  • 醫生/醫療服務提供者和醫院
  • 政府機構
  • 診斷中心
  • 患者
  • 其他
第6章全球膽固醇篩檢/膽固醇實驗室檢測服務市場(按地區)
  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
    亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第7章 全球膽固醇篩檢/膽固醇實驗室檢測服務市場:競爭格局

  • 概述
  • 公司市佔率
  • 供應商概況
  • 主要發展策略

第 8 章 公司簡介

  • Laboratory Corporation of America Holdings(LabCorp)
  • Quest Diagnostics Incorporated
  • Eurofins Scientific
  • Spectra Laboratories, Inc.
  • Unilabs
  • Synlab International GmbH
  • Bio-Reference Laboratories, Inc.
  • Clinical Reference Laboratory, Inc.
  • ACM Medical Laboratory
  • Adicon Clinical Laboratory

第9章 附錄

  • 相關報告
簡介目錄
Product Code: 24129

Cholesterol Screening/Cholesterol Lab Testing Services Market Size And Forecast

Cholesterol Screening/Cholesterol Lab Testing Services Market size was valued at USD 15.4 Billion in 2020 and is projected to reachUSD 28.6 Billion by 2028, growing at aCAGR of 7.9% from 2021 to 2028.

The increased incidence of cardiovascular disease and obesity, doctors' preference for laboratory testing over self-testing, government initiatives to improve test quality, and the rapid growth of the geriatric population are driving the growth of the Cholesterol Screening/Cholesterol Lab Testing Services Market. The Global Cholesterol Screening/Cholesterol Lab Testing Services Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Definition

The pervasiveness of inactive lifestyles is expected to increase the demand for cholesterol laboratory tests around the world. Cholesterol is a waxy, fat-like substance that is present in the bloodstream, in nerve fibers, and body organs. A person's cholesterol level is determined by factors such as heredity, consumption of foods high in saturated fatty acids like animal products, and metabolic diseases such as diabetes, age, and gender.

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Overview

Elevated cholesterol level increases health risks such as a high risk of stroke and heart disease, which are responsible for a large number of deaths. Cholesterol laboratory tests enable problems to be detected early, avoid complications and increase the patient's chances of survival which drives the growth of the Cholesterol Screening/Cholesterol Lab Testing Services Market.

Other important drivers of market growth are the gradual awareness of the dangers of cholesterol and education about the importance of these tests, the increasing incidence of cardiovascular diseases, strokes, and other heart diseases, the growth in health care spending, government initiatives, the increase in the geriatric population and technological advances in cholesterol laboratory testing services, low consumption of fruits and vegetables, unhealthy food habits such as liking for fast food and fast food, and lack of physical inactivity have fueled the growth of this market.

Obesity is another condition related to high cholesterol. As the number of cholesterol-induced diseases increases, so will the need for these tests, expanding the market for global laboratory cholesterol testing. However, the presence of home or self-test kits could restrict the growth in addition to the limitations imposed by the introduction of non-invasive cholesterol testing procedures.

Global Cholesterol Screening/Cholesterol Lab Testing Services Market Segmentation Analysis

The Global Cholesterol Screening/Cholesterol Lab Testing Services Market is Segmented on the basis of Type of Customer And Geography.

Cholesterol Screening/Cholesterol Lab Testing Services Market, By Type Of Customer

  • Physicians/Providers and Hospitals
  • Government Agencies
  • Diagnostic centers
  • Patients
  • Others

Based on Type Of Customer, The market is segmented into Physicians/Providers and Hospitals, Government Agencies, Diagnostic centers, Patients, and Others. Diagnostic Centres dominated the market in terms of total revenue share and are also expected to have the fastest CAGR during the forecast period due to the increasing number of people diagnosed with high total cholesterol. Furthermore, regular health checkups without the doctors' Interventions are also a powerful driver of growth. The Government segment is expected to experience significant growth in the forecast period due to its increasing focus on prevention and early detection to avoid serious illnesses.

Cholesterol Screening/Cholesterol Lab Testing Services Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, The Global Cholesterol Screening/Cholesterol Lab Testing Services Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America is expected to dominate the global Cholesterol Screening/Cholesterol Lab Testing Services Market, with the United States having a significant share. Asia is projected to be the fastest-growing region in terms of CAGR. Due to the large population base, increased prevalence of cardiovascular disease, and a growing number of testing facilities in the Asia region over the forecast period.

Key Players

  • The "Global Cholesterol Screening/Cholesterol Lab Testing Services Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as
  • Laboratory Corporation of America Holdings (LabCorp), Quest Diagnostics Incorporated, Eurofins Scientific, Spectra Laboratories, Inc., Unilabs, Synlab International GmbH, Bio-Reference Laboratories, Inc., Clinical Reference Laboratory, Inc., ACM Medical Laboratory, and Adicon Clinical Laboratory.
  • The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET, BY TYPE OF CUSTOMER

  • 5.1 Overview
  • 5.2 Physicians/Providers and Hospitals
  • 5.3 Government Agencies
  • 5.4 Diagnostic centers
  • 5.5 Patients
  • 5.6 Others

6 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET, BY GEOGRAPHY

  • 6.1 Overview
  • 6.2 North America
    • 6.2.1 U.S.
    • 6.2.2 Canada
    • 6.2.3 Mexico
  • 6.3 Europe
    • 6.3.1 Germany
    • 6.3.2 U.K.
    • 6.3.3 France
    • 6.3.4 Rest of Europe
  • 6.4 Asia Pacific
    • 6.4.1 China
    • 6.4.2 Japan
    • 6.4.3 India
    • 6.4.4 Rest of Asia Pacific
  • 6.5 Rest of the World
    • 6.5.1 Latin America
    • 6.5.2 Middle East & Africa

7 GLOBAL CHOLESTEROL SCREENING/CHOLESTEROL LAB TESTING SERVICES MARKET COMPETITIVE LANDSCAPE

  • 7.1 Overview
  • 7.2 Company Market Share
  • 7.3 Vendor Landscape
  • 7.4 Key Development Strategies

8 COMPANY PROFILES

  • 8.1 Laboratory Corporation of America Holdings (LabCorp)
    • 8.1.1 Overview
    • 8.1.2 Financial Performance
    • 8.1.3 Product Outlook
    • 8.1.4 Key Developments
  • 8.2 Quest Diagnostics Incorporated
    • 8.2.1 Overview
    • 8.2.2 Financial Performance
    • 8.2.3 Product Outlook
    • 8.2.4 Key Developments
  • 8.3 Eurofins Scientific
    • 8.3.1 Overview
    • 8.3.2 Financial Performance
    • 8.3.3 Product Outlook
    • 8.3.4 Key Developments
  • 8.4 Spectra Laboratories, Inc.
    • 8.4.1 Overview
    • 8.4.2 Financial Performance
    • 8.4.3 Product Outlook
    • 8.4.4 Key Developments
  • 8.5 Unilabs
    • 8.5.1 Overview
    • 8.5.2 Financial Performance
    • 8.5.3 Product Outlook
    • 8.5.4 Key Developments
  • 8.6 Synlab International GmbH
    • 8.6.1 Overview
    • 8.6.2 Financial Performance
    • 8.6.3 Product Outlook
    • 8.6.4 Key Developments
  • 8.7 Bio-Reference Laboratories, Inc.
    • 8.7.1 Overview
    • 8.7.2 Financial Performance
    • 8.7.3 Product Outlook
    • 8.7.4 Key Developments
  • 8.8 Clinical Reference Laboratory, Inc.
    • 8.8.1 Overview
    • 8.8.2 Financial Performance
    • 8.8.3 Product Outlook
    • 8.8.4 Key Developments
  • 8.9 ACM Medical Laboratory)
    • 8.9.1 Overview
    • 8.9.2 Financial Performance
    • 8.9.3 Product Outlook
    • 8.9.4 Key Developments
  • 8.10 Adicon Clinical Laboratory
    • 8.10.1 Overview
    • 8.10.2 Financial Performance
    • 8.10.3 Product Outlook
    • 8.10.4 Key Developments

9 Appendix

  • 9.1 Related Reports